Sudhakar Kancharla

Healthcare is entering a phase in which diagnostics are no longer just a back-end function. It is becoming the intelligence layer that powers clinical decision-making. For hospitals, clinics, and healthcare networks, the focus is shifting from testing capacity to how effectively diagnostics can enable faster, more accurate, and more personalized care.

This shift is driven by the convergence of artificial intelligence and genomics, working together as integrated systems that strengthen how healthcare providers operate. 

How AI is Transforming Diagnostics into a Clinical Intelligence Layer

Traditionally, diagnostics has been a service function centered on sample collection, processing, and reporting. While this built scale, interpretation often remained fragmented. AI is now enabling diagnostics to evolve into a decision-support system. With the inclusion of laboratory findings along with the patient’s medical history and genetics, today’s reports have transcended the concept of numbers and their ranges. 

These reports not only offer valuable information but also highlight early signs of potential risks. This makes physicians’ work much easier by allowing them to spend less time decoding reports and more time making decisions.

How AI Improves Turnaround Time, Efficiency, and Diagnostic Accuracy

For hospitals and clinics, time directly impacts both patient outcomes and operational efficiency. AI-driven workflows reduce timelines across the diagnostic chain.  From automated sample tracking to assisted report generation, processes become faster and more reliable. Turnaround times reduce without compromising quality, which is critical in both routine and specialized testing.

Take advanced tests such as the Folate Receptor Antibody Test (FRAT). Earlier, identifying biological contributors in developmental conditions required multiple layers of testing. Today, FRAT can be conducted through a single blood sample, with results delivered within 5–7 days. For clinicians, this means greater clarity earlier. For institutions, it reduces repeat testing and builds stronger patient trust.

Integrating Genomics into Everyday Clinical Decision-Making

Genomics is rapidly moving from specialized labs into everyday clinical workflows. Modern genomic platforms today combine whole exome sequencing with SNP microarray analysis to deliver comprehensive insights that are clinically usable through tests like DNA Decoder. Here, the focus is not just on data depth but on usability. Therefore, reports are structured into modules aligned with global frameworks such as ACMG and CPIC, making them easier to interpret and apply.

Apart from this, Pharmacogenomics helps clinicians understand how patients respond to medications, reducing adverse reactions and improving treatment precision.
Nutrigenomics enables more personalized nutrition guidance based on genetic predisposition. To operationalize this, tests like MedMatch are also emerging to connect genomic insights with actionable care pathways, helping clinicians translate complex data into real decisions. 

FRAT and the Role of Insights in Early Intervention

In areas like developmental health, diagnostics often rely heavily on behavioral observation, which can delay biological understanding. The FRAT test introduces an early insight approach by identifying folate receptor autoantibodies that may affect the delivery of folate to the brain.

Out of the first groups tested by Yoda Diagnostics, which included more than 600 children, close to 75% were found to be FRAT positive. Of those who underwent intervention using folinic acid, many showed improved levels of communication within months.

From a health care perspective, this is not a replacement for diagnosis. Rather, it enhances it by providing a biological dimension to an already existing process.

Scaling AI and Genomics Through Partnerships and Market Expansion 

The future of diagnostics will be shaped by its ability to integrate seamlessly into the larger healthcare ecosystem. There is a clear synergy between government-led efforts and private healthcare organizations that are building out digital infrastructure and preventive healthcare programs. The idea is to bring AI and genomics into the workflow process for healthcare providers rather than keeping them separate.

On the other hand, many diagnostics brands are looking to scale beyond Tier 1 cities. Through their central laboratory facilities and digitalization efforts, they want to ensure that healthcare providers based in Tier 2 and Tier 3 cities can utilize the same technology and services.

There are also efforts at a global level towards forming partnerships in countries that are moving towards preventive and personalized healthcare.

Also read: MedVital Secures ₹18 Cr Funding to Expand Advanced Wound Care and Regenerative Aesthetics Portfolio

The Future of Diagnostics: Where AI Meets Genomics 

Diagnostics is steadily moving beyond identifying what has already gone wrong. It is becoming a continuous layer of intelligence that supports every stage of care. AI brings speed and consistency, while genomics adds depth and personalization.

When these come together in a clinical setting, decisions become faster, uncertainty reduces, and both doctors and patients gain greater confidence. For healthcare providers, this means not just handling higher volumes but doing so with greater clarity and precision.

At Yoda Diagnostics, we see it as a steady evolution where diagnostics become an active, informed, and reliable part of healthcare delivery. 

Views expressed by: Sudhakar Kancharla, Founder, Mr. Yoda


Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Disclaimer: The views and opinions expressed in this article are solely those of the author and do not necessarily reflect the official policy or views of any organisation. The content is intended for informational and educational purposes only and should not be construed as medical advice.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!

Related Article


whatsapp--v1 JOIN US
whatsapp--v1